320 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Vermeulen JM, van den Brink W, de Haan L. The Unhealthy Chicken or the Unhealthy Egg: Quitting Smoking Matters: Response to Hajek et al. The American Journal of Psychiatry. 176: 575-576. PMID 31256619 DOI: 10.1176/appi.ajp.2019.18111257r  0.6
2019 Jansen JM, van den Heuvel OA, van der Werf YD, de Wit SJ, Veltman DJ, van den Brink W, Goudriaan AE. Emotion Processing, Reappraisal, and Craving in Alcohol Dependence: A Functional Magnetic Resonance Imaging Study. Frontiers in Psychiatry. 10: 227. PMID 31057439 DOI: 10.3389/fpsyt.2019.00227  1
2019 Raposo Pereira F, McMaster MTB, de Vries YDAT, Polderman N, van den Brink W, van Wingen GA. Influence of Gamma-Hydroxybutyric Acid-Use and Gamma-Hydroxybutyric Acid-Induced Coma on Affect and the Affective Network. European Addiction Research. 1-9. PMID 30999293 DOI: 10.1159/000497381  0.88
2019 van Emmerik-van Oortmerssen K, Vedel E, Kramer FJ, Blankers M, Dekker JJM, van den Brink W, Schoevers RA. Integrated cognitive behavioral therapy for ADHD in adult substance use disorder patients: Results of a randomized clinical trial. Drug and Alcohol Dependence. 197: 28-36. PMID 30769263 DOI: 10.1016/j.drugalcdep.2018.12.023  1
2018 Raposo Pereira F, McMaster MTB, Polderman N, de Vries YDAT, van den Brink W, van Wingen GA. Effect of GHB-use and GHB-induced comas on dorsolateral prefrontal cortex functioning in humans. Neuroimage. Clinical. 20: 923-930. PMID 30308378 DOI: 10.1016/j.nicl.2018.09.022  0.88
2018 van Amsterdam J, Vervloet J, de Weert G, Buwalda VJA, Goudriaan AE, van den Brink W. Acceptance of pharmaceutical cannabis substitution by cannabis using patients with schizophrenia. Harm Reduction Journal. 15: 47. PMID 30236118 DOI: 10.1186/s12954-018-0253-7  1
2018 Raposo Pereira F, McMaster MTB, Polderman N, de Vries YDAT, van den Brink W, van Wingen GA. Adverse effects of GHB-induced coma on long-term memory and related brain function. Drug and Alcohol Dependence. 190: 29-36. PMID 29966850 DOI: 10.1016/j.drugalcdep.2018.05.019  0.88
2018 Schulte MHJ, Wiers RW, Boendermaker WJ, Goudriaan AE, van den Brink W, van Deursen DS, Friese M, Brede E, Waters AJ. Reprint of The effect of N-acetylcysteine and working memory training on cocaine use, craving and inhibition in regular cocaine users: correspondence of lab assessments and Ecological Momentary Assessment. Addictive Behaviors. PMID 29661657 DOI: 10.1016/j.addbeh.2018.03.023  1
2018 Herbrink M, Nuijten M, Nuijen B, Huitema ADR, Beijnen JH, Hendriks VM, Blanken P, Janmohamed A, van den Brink W. Pharmacokinetics of Sustained-Release Oral Dexamphetamine Sulfate in Cocaine and Heroin-Dependent Patients. Journal of Clinical Psychopharmacology. 38: 212-217. PMID 29620701 DOI: 10.1097/JCP.0000000000000862  0.6
2017 Schipper R, Dekker M, de Haan L, van den Brink W. Medicinal cannabis (Bedrolite) substitution therapy in inpatients with a psychotic disorder and a comorbid cannabis use disorder: A case series. Journal of Psychopharmacology (Oxford, England). 269881117735684. PMID 29039260 DOI: 10.1177/0269881117735684  0.6
2017 van Emmerik-van Oortmerssen K, Vedel E, Kramer FJ, Koeter MW, Schoevers RA, van den Brink W. Diagnosing ADHD during active substance use: Feasible or flawed? Drug and Alcohol Dependence. 180: 371-375. PMID 28957778 DOI: 10.1016/j.drugalcdep.2017.07.039  1
2017 Beraha EM, Salemink E, Goudriaan AE, van den Brink W, Wiers RW. Response to "Baclofen and alcohol use disorders: From miracle to mirage". European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 28576349 DOI: 10.1016/j.euroneuro.2017.05.002  1
2017 Machielsen MW, Veltman DJ, van den Brink W, de Haan L. Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: A randomized fMRI study. Schizophrenia Research. PMID 28351544 DOI: 10.1016/j.schres.2017.03.030  1
2016 Gevonden M, Myin-Germeys I, Wichers M, Booij J, van den Brink W, van Winkel R, Selten JP. Reactivity to social stress in ethnic minority men. Psychiatry Research. PMID 27884461 DOI: 10.1016/j.psychres.2016.10.076  1
2016 Zaaijer ER, Goudriaan AE, Koeter MW, Booij J, van den Brink W. Acceptability of Extended-Release Naltrexone by Heroin-Dependent Patients and Addiction Treatment Providers in the Netherlands. Substance Use & Misuse. 1-7. PMID 27613150 DOI: 10.1080/10826084.2016.1201117  1
2016 Kaag AM, Schluter RS, Karel P, Homberg J, van den Brink W, Reneman L, van Wingen GA. Aversive Counterconditioning Attenuates Reward Signaling in the Ventral Striatum. Frontiers in Human Neuroscience. 10: 418. PMID 27594829 DOI: 10.3389/fnhum.2016.00418  0.88
2016 Cohn MD, Viding E, McCrory E, Pape L, van den Brink W, Doreleijers TA, Veltman DJ, Popma A. Regional grey matter volume and concentration in at-risk adolescents: Untangling associations with callous-unemotional traits and conduct disorder symptoms. Psychiatry Research. 254: 180-187. PMID 27479922 DOI: 10.1016/j.pscychresns.2016.07.003  1
2016 Tuithof M, Ten Have M, van den Brink W, Vollebergh W, de Graaf R. Treatment Seeking for Alcohol Use Disorders: Treatment Gap or Adequate Self-Selection. European Addiction Research. 22: 277-285. PMID 27287873 DOI: 10.1159/000446822  0.64
2016 Koenders L, Cousijn J, Vingerhoets WA, van den Brink W, Wiers RW, Meijer CJ, Machielsen MW, Veltman DJ, Goudriaan AE, de Haan L. Grey Matter Changes Associated with Heavy Cannabis Use: A Longitudinal sMRI Study. Plos One. 11: e0152482. PMID 27224247 DOI: 10.1371/journal.pone.0152482  1
2016 Kaag AM, Levar N, Woutersen K, Homberg J, van den Brink W, Reneman L, van Wingen G. Hyperresponsiveness of the Neural Fear Network During Fear Conditioning and Extinction Learning in Male Cocaine Users. The American Journal of Psychiatry. appiajp201615040433. PMID 27079132 DOI: 10.1176/appi.ajp.2016.15040433  0.88
2016 Nuijten M, Blanken P, van de Wetering B, Nuijen B, van den Brink W, Hendriks VM. Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial. Lancet (London, England). PMID 27015909 DOI: 10.1016/S0140-6736(16)00205-1  0.6
2016 Kaag AM, van Wingen GA, Caan MW, Homberg JR, van den Brink W, Reneman L. White matter alterations in cocaine users are negatively related to the number of additionally (ab)used substances. Addiction Biology. PMID 26860848 DOI: 10.1111/adb.12375  0.88
2016 Kronenberg LM, Goossens PJ, van Busschbach JT, van Achterberg T, van den Brink W. Burden and Expressed Emotion of Caregivers in Cases of Adult Substance Use Disorder with and Without Attention Deficit/Hyperactivity Disorder or Autism Spectrum Disorder. International Journal of Mental Health and Addiction. 14: 49-63. PMID 26798327 DOI: 10.1007/s11469-015-9567-9  1
2016 Kiefer F, van den Brink W, Gual A, Mann K. European Addiction Research Becomes the Official Journal of the European Federation of Addiction Societies. European Addiction Research. 22: I-II. PMID 26731125 DOI: 10.1159/000443346  1
2015 Figee M, Pattij T, Willuhn I, Luigjes J, van den Brink W, Goudriaan A, Potenza MN, Robbins TW, Denys D. Compulsivity in obsessive-compulsive disorder and addictions. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26774279 DOI: 10.1016/j.euroneuro.2015.12.003  0.84
2015 Sjoerds Z, Stufflebeam SM, Veltman DJ, Van den Brink W, Penninx BW, Douw L. Loss of brain graph network efficiency in alcohol dependence. Addiction Biology. PMID 26692359 DOI: 10.1111/adb.12346  1
2015 Welten CC, Koeter MW, Wohlfarth TD, Storosum JG, van den Brink W, Gispen-de Wied CC, Leufkens HG, Denys DA. Does Insight Affect the Efficacy of Antipsychotics in Acute Mania?: An Individual Patient Data Regression Meta-Analysis. Journal of Clinical Psychopharmacology. PMID 26647231 DOI: 10.1097/JCP.0000000000000435  1
2015 Vingerhoets W, Koenders L, van den Brink W, Wiers RW, Goudriaan AE, van Amelsvoort T, de Haan L, Cousijn J. Cue-induced striatal activity in frequent cannabis users independently predicts cannabis problem severity three years later. Journal of Psychopharmacology (Oxford, England). PMID 26645206 DOI: 10.1177/0269881115620436  1
2015 van Amsterdam J, Nabben T, van den Brink W. Recreational nitrous oxide use: Prevalence and risks. Regulatory Toxicology and Pharmacology : Rtp. PMID 26496821 DOI: 10.1016/j.yrtph.2015.10.017  1
2015 Jansen JM, Wingen GV, Brink WV, Goudriaan AE. Resting state connectivity in alcohol dependent patients and the effect of repetitive transcranial magnetic stimulation. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26481907 DOI: 10.1016/j.euroneuro.2015.09.019  1
2015 van Amsterdam J, Phillips L, Henderson G, Bell J, Bowden-Jones O, Hammersley R, Ramsey J, Taylor P, Dale-Perera A, Melichar J, van den Brink W, Nutt D. Ranking the harm of non-medically used prescription opioids in the UK. Regulatory Toxicology and Pharmacology : Rtp. PMID 26382614 DOI: 10.1016/j.yrtph.2015.09.014  1
2015 Pape LE, Cohn MD, Caan MW, van Wingen G, van den Brink W, Veltman DJ, Popma A. Psychopathic traits in adolescents are associated with higher structural connectivity. Psychiatry Research. 233: 474-80. PMID 26272037 DOI: 10.1016/j.pscychresns.2015.07.023  1
2015 Stringer S, Cerrone KC, van den Brink W, van den Berg JF, Denys D, Kahn RS, Derks EM. A guide on gene prioritization in studies of psychiatric disorders. International Journal of Methods in Psychiatric Research. PMID 26230968 DOI: 10.1002/mpr.1482  1
2015 Crunelle CL, Kaag AM, van den Munkhof HE, Reneman L, Homberg JR, Sabbe B, van den Brink W, van Wingen G. Dysfunctional amygdala activation and connectivity with the prefrontal cortex in current cocaine users. Human Brain Mapping. 36: 4222-30. PMID 26220024 DOI: 10.1002/hbm.22913  1
2015 Kronenberg LM, Goossens PJ, van Busschbach J, van Achterberg T, van den Brink W. Coping styles in substance use disorder (SUD) patients with and without co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). Bmc Psychiatry. 15: 159. PMID 26169586 DOI: 10.1186/s12888-015-0530-x  1
2015 Kronenberg LM, Verkerk-Tamminga R, Goossens PJ, van den Brink W, van Achterberg T. Personal recovery in individuals diagnosed with substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). Archives of Psychiatric Nursing. 29: 242-8. PMID 26165980 DOI: 10.1016/j.apnu.2015.04.006  1
2015 Welten CC, Koeter MW, Wohlfarth TD, Storosum JG, van den Brink W, Gispen-de Wied CC, Leufkens HG, Denys DA. Net gain analysis, an addition to responder analysis - The case of antipsychotic treatment of acute mania. Regulatory Toxicology and Pharmacology : Rtp. 73: 227-31. PMID 26164267 DOI: 10.1016/j.yrtph.2015.06.020  1
2015 Strang J, Groshkova T, Uchtenhagen A, van den Brink W, Haasen C, Schechter MT, Lintzeris N, Bell J, Pirona A, Oviedo-Joekes E, Simon R, Metrebian N. Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction†. The British Journal of Psychiatry : the Journal of Mental Science. 207: 5-14. PMID 26135571 DOI: 10.1192/bjp.bp.114.149195  1
2015 van Amsterdam J, van den Brink W. The Misuse of Prescription Opioids: A Threat for Europe? Current Drug Abuse Reviews. 8: 3-14. PMID 26084418  1
2015 Cohn MD, van Lith K, Kindt M, Pape LE, Doreleijers TA, Brink WV, Veltman DJ, Popma A. Fear extinction, persistent disruptive behavior and psychopathic traits: fMRI in late adolescence. Social Cognitive and Affective Neuroscience. PMID 26048179 DOI: 10.1093/scan/nsv067  1
2015 van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M. Three-Year Course of Cannabis Dependence and Prediction of Persistence. European Addiction Research. 21: 279-290. PMID 26044258 DOI: 10.1159/000377625  1
2015 Welten CC, Koeter MW, Wohlfarth TD, Storosum JG, van den Brink W, Gispen-de Wied CC, Leufkens HG, Denys DA. Efficacy of drug treatment for acute mania differs across geographic regions: An individual patient data meta-analysis of placebo-controlled studies. Journal of Psychopharmacology (Oxford, England). 29: 923-32. PMID 26038109 DOI: 10.1177/0269881115586938  1
2015 Maraz A, van den Brink W, Demetrovics Z. Prevalence and construct validity of compulsive buying disorder in shopping mall visitors. Psychiatry Research. 228: 918-24. PMID 26027442 DOI: 10.1016/j.psychres.2015.04.012  1
2015 Nuijten M, Blanken P, van den Brink W, Hendriks V. Modafinil in the treatment of crack-cocaine dependence in the Netherlands: Results of an open-label randomised controlled feasibility trial. Journal of Psychopharmacology (Oxford, England). 29: 678-87. PMID 25922424 DOI: 10.1177/0269881115582151  1
2015 van Amsterdam J, Nutt D, Phillips L, van den Brink W. European rating of drug harms. Journal of Psychopharmacology (Oxford, England). 29: 655-60. PMID 25922421 DOI: 10.1177/0269881115581980  1
2015 Welten CC, Koeter MW, Wohlfarth T, Storosum JG, van den Brink W, Gispen-de Wied CC, Leufkens HG, Denys DA. Placebo response in antipsychotic trials of patients with acute mania: Results of an individual patient data meta-analysis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 1018-26. PMID 25907248 DOI: 10.1016/j.euroneuro.2015.03.010  1
2015 Houwert-Steins Bisschop CN, Zantvoord JB, Machielsen MW, Koeter M, van den Brink W. [In Process Citation]. Tijdschrift Voor Psychiatrie. 57: 305-8. PMID 25904435  0.84
2015 Zandi T, Havenaar JM, Laan W, Kahn RS, Brink WV. Effects of a culturally sensitive assessment on symptom profiles in native Dutch and Moroccan patients with a first psychosis referral. Transcultural Psychiatry. PMID 25851336 DOI: 10.1177/1363461515577288  0.84
2015 Wapp M, van de Glind G, van Emmerik-van Oortmerssen K, Dom G, Verspreet S, Carpentier PJ, Ramos-Quiroga JA, Skutle A, Bu ET, Franck J, Konstenius M, Kaye S, Demetrovics Z, Barta C, Fatséas M, ... ... van den Brink W, et al. Risk Factors for Borderline Personality Disorder in Treatment Seeking Patients with a Substance Use Disorder: An International Multicenter Study. European Addiction Research. 21: 188-94. PMID 25832736 DOI: 10.1159/000371724  1
2015 Young JT, Carruthers S, Kaye S, Allsop S, Gilsenan J, Degenhardt L, van de Glind G, van den Brink W, Preen D. Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment-seeking adults. Drug and Alcohol Review. PMID 25790353 DOI: 10.1111/dar.12249  1
2015 Luigjes J, van den Brink W, Schuurman PR, Kuhn J, Denys D. Is deep brain stimulation a treatment option for addiction? Addiction (Abingdon, England). 110: 547-8. PMID 25771687 DOI: 10.1111/add.12773  1
2015 Cohn MD, Pape LE, Schmaal L, van den Brink W, van Wingen G, Vermeiren RR, Doreleijers TA, Veltman DJ, Popma A. Differential relations between juvenile psychopathic traits and resting state network connectivity. Human Brain Mapping. 36: 2396-405. PMID 25757797 DOI: 10.1002/hbm.22779  1
2015 Zaaijer ER, van Dijk L, de Bruin K, Goudriaan AE, Lammers LA, Koeter MW, van den Brink W, Booij J. Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients. Psychopharmacology. 232: 2597-607. PMID 25757673 DOI: 10.1007/s00213-015-3891-4  1
2015 Nutt DJ, Rehm J, van den Brink W, Gorwood P, Buchsbaum MS. Progress in mind: focus on alcohol use disorders, an elsevier resource centre. Psychiatry Research. 226: 513-4. PMID 25724487 DOI: 10.1016/j.psychres.2015.01.013  1
2015 van Emmerik-van Oortmerssen K, Vedel E, van den Brink W, Schoevers RA. Integrated cognitive behavioral therapy for patients with substance use disorder and comorbid ADHD: two case presentations. Addictive Behaviors. 45: 214-7. PMID 25706067 DOI: 10.1016/j.addbeh.2015.01.040  1
2015 van den Brink W, Strang J, Gual A, Sørensen P, Jensen TJ, Mann K. Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme. Expert Opinion On Drug Safety. 14: 495-504. PMID 25652768 DOI: 10.1517/14740338.2015.1011619  1
2015 Zaaijer ER, de Bruin K, la Fleur SE, Goudriaan AE, van den Brink W, Booij J. Subchronic administration of short-acting naltrexone has no effect on striatal dopamine transporter availability, food intake or body weight gain in rats. Journal of Psychopharmacology (Oxford, England). 29: 344-8. PMID 25586403 DOI: 10.1177/0269881114565380  1
2015 van Amsterdam J, Brunt T, van den Brink W. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects. Journal of Psychopharmacology (Oxford, England). 29: 254-63. PMID 25586398 DOI: 10.1177/0269881114565142  1
2015 Mattila T, Koeter M, Wohlfarth T, Storosum J, van den Brink W, de Haan L, Derks E, Leufkens H, Denys D. Impact of DSM-5 changes on the diagnosis and acute treatment of schizophrenia. Schizophrenia Bulletin. 41: 637-43. PMID 25528758 DOI: 10.1093/schbul/sbu172  1
2015 Koenders L, Machielsen MW, van der Meer FJ, van Gasselt AC, Meijer CJ, van den Brink W, Koeter MW, Caan MW, Cousijn J, den Braber A, van 't Ent D, Rive MM, Schene AH, van de Giessen E, Huyser C, et al. Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders. Journal of Psychiatry & Neuroscience : Jpn. 40: 197-206. PMID 25510948 DOI: 10.1503/jpn.140081  1
2015 Gevonden MJ, Myin-Germeys I, van den Brink W, van Os J, Selten JP, Booij J. Psychotic reactions to daily life stress and dopamine function in people with severe hearing impairment. Psychological Medicine. 45: 1665-74. PMID 25482840 DOI: 10.1017/S0033291714002797  1
2015 Uhl A, Hunt G, van den Brink W, Stimson GV. How credible are international databases for understanding substance use and related problems? The International Journal On Drug Policy. 26: 119-21. PMID 25477287 DOI: 10.1016/j.drugpo.2014.10.014  1
2015 Bongers P, van de Giessen E, Roefs A, Nederkoorn C, Booij J, van den Brink W, Jansen A. Being impulsive and obese increases susceptibility to speeded detection of high-calorie foods. Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 34: 677-85. PMID 25365413 DOI: 10.1037/hea0000167  1
2015 Benschop A, Liebregts N, van der Pol P, Schaap R, Buisman R, van Laar M, van den Brink W, de Graaf R, Korf DJ. Reliability and validity of the Marijuana Motives Measure among young adult frequent cannabis users and associations with cannabis dependence. Addictive Behaviors. 40: 91-5. PMID 25240105 DOI: 10.1016/j.addbeh.2014.09.003  1
2015 Heytens L, Neels H, Van Regenmortel N, van den Brink W, Henckes M, Schouwers S, Dockx G, Crunelle CL. Near-fatal persistent anion- and osmolal-gap acidosis due to massive gamma-butyrolactone/ethanol intoxication. Annals of Clinical Biochemistry. 52: 283-7. PMID 25205856 DOI: 10.1177/0004563214553278  1
2015 Liebregts N, van der Pol P, van Laar M, de Graaf R, van den Brink W, Korf DJ. The role of leisure and delinquency in frequent cannabis use and dependence trajectories among young adults. The International Journal On Drug Policy. 26: 143-52. PMID 25171910 DOI: 10.1016/j.drugpo.2014.07.014  1
2015 Sizoo BB, van der Gaag RJ, van den Brink W. Temperament and character as endophenotype in adults with autism spectrum disorders or attention deficit/hyperactivity disorder. Autism : the International Journal of Research and Practice. 19: 400-8. PMID 24535690 DOI: 10.1177/1362361314522352  1
2015 Kronenberg LM, Goossens PJ, van Etten DM, van Achterberg T, van den Brink W. Need for care and life satisfaction in adult substance use disorder patients with and without attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). Perspectives in Psychiatric Care. 51: 4-15. PMID 24410895 DOI: 10.1111/ppc.12056  1
2015 Liebregts N, van der Pol P, de Graaf R, van Laar M, van den Brink W, Korf DJ. Persistence and desistance in heavy cannabis use: the role of identity, agency, and life events Journal of Youth Studies. 18: 617-633. DOI: 10.1080/13676261.2014.992320  1
2015 Skutle A, Bu ETH, Jellestad FK, van Emmerik-van Oortmerssen K, Dom G, Verspreet S, Carpentier PJ, Ramos-Quiroga JA, Franck J, Konstenius M, Kaye S, Demetrovics Z, Barta C, Fatséas M, Auriacombe M, ... ... van den Brink W, et al. Early developmental, temperamental and educational problems in 'substance use disorder' patients with and without ADHD: Does ADHD make a difference? Addictive Behaviors Reports. 2: 13-18. DOI: 10.1016/j.abrep.2015.03.001  1
2015 Van Amsterdam JGC, Wartenberg HHC, Van Den Brink W. Steep increase in prescribed opioids in The Netherlands. Are we going the same way as the U.S.? | Forse toename voorgeschreven opioïden in Nederland: Dreigen hier amerikaanse toestanden? Nederlands Tijdschrift Voor Geneeskunde. 159.  1
2015 Houwert-Steins Bisschop CN, Zantvoord JB, Machielsen MWJ, Koeter MWJ, Van Den Brink W. Reaction to: "Dose reduction strategy in place of maintenance therapy after first-episode psychosis: Long-term recovery is twice as often" | Reactie op Tijdschrift Voor Psychiatrie. 57: 305-306.  1
2014 Cohn MD, Veltman DJ, Pape LE, van Lith K, Vermeiren RR, van den Brink W, Doreleijers TA, Popma A. Incentive Processing in Persistent Disruptive Behavior and Psychopathic Traits: A Functional Magnetic Resonance Imaging Study in Adolescents. Biological Psychiatry. PMID 25497690 DOI: 10.1016/j.biopsych.2014.08.017  1
2014 Jansen JM, van Holst RJ, van den Brink W, Veltman DJ, Caan MW, Goudriaan AE. Brain function during cognitive flexibility and white matter integrity in alcohol-dependent patients, problematic drinkers and healthy controls. Addiction Biology. PMID 25477246 DOI: 10.1111/adb.12199  1
2014 Zaaijer ER, Bruijel J, Blanken P, Hendriks V, Koeter MW, Kreek MJ, Booij J, Goudriaan AE, van Ree JM, van den Brink W. Personality as a risk factor for illicit opioid use and a protective factor for illicit opioid dependence. Drug and Alcohol Dependence. 145: 101-5. PMID 25454407 DOI: 10.1016/j.drugalcdep.2014.09.783  1
2014 Matthys F, Soyez V, van den Brink W, Joostens P, Tremmery S, Sabbe B. Barriers to implementation of treatment guidelines for ADHD in adults with substance use disorder. Journal of Dual Diagnosis. 10: 130-8. PMID 25392286 DOI: 10.1080/15504263.2014.926691  1
2014 Romanczuk-Seiferth N, van den Brink W, Goudriaan AE. From symptoms to neurobiology: pathological gambling in the light of the new classification in DSM-5. Neuropsychobiology. 70: 95-102. PMID 25359489 DOI: 10.1159/000362839  1
2014 Merkx MJ, Schippers GM, Koeter MW, De Wildt WA, Vedel E, Goudriaan AE, Van Den Brink W. Treatment outcome of alcohol use disorder outpatients with or without medically assisted detoxification. Journal of Studies On Alcohol and Drugs. 75: 993-8. PMID 25343657  1
2014 Kaag AM, Crunelle CL, van Wingen G, Homberg J, van den Brink W, Reneman L. Relationship between trait impulsivity and cortical volume, thickness and surface area in male cocaine users and non-drug using controls. Drug and Alcohol Dependence. 144: 210-7. PMID 25278147 DOI: 10.1016/j.drugalcdep.2014.09.016  1
2014 Gevonden M, Booij J, van den Brink W, Heijtel D, van Os J, Selten JP. Increased release of dopamine in the striata of young adults with hearing impairment and its relevance for the social defeat hypothesis of schizophrenia. Jama Psychiatry. 71: 1364-72. PMID 25271822 DOI: 10.1001/jamapsychiatry.2014.1325  1
2014 Schulte MH, Cousijn J, den Uyl TE, Goudriaan AE, van den Brink W, Veltman DJ, Schilt T, Wiers RW. Recovery of neurocognitive functions following sustained abstinence after substance dependence and implications for treatment. Clinical Psychology Review. 34: 531-50. PMID 25240109 DOI: 10.1016/j.cpr.2014.08.002  1
2014 Kronenberg LM, Slager-Visscher K, Goossens PJ, van den Brink W, van Achterberg T. Everyday life consequences of substance use in adult patients with a substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD): a patient's perspective. Bmc Psychiatry. 14: 264. PMID 25234344 DOI: 10.1186/s12888-014-0264-1  1
2014 van Amsterdam J, Brunt T, Pennings E, van den Brink W. Risk assessment of GBL as a substitute for the illicit drug GHB in the Netherlands. A comparison of the risks of GBL versus GHB. Regulatory Toxicology and Pharmacology : Rtp. 70: 507-13. PMID 25204614 DOI: 10.1016/j.yrtph.2014.08.014  1
2014 Kaye S, Gilsenan J, Young JT, Carruthers S, Allsop S, Degenhardt L, van de Glind G, van den Brink W. Risk behaviours among substance use disorder treatment seekers with and without adult ADHD symptoms. Drug and Alcohol Dependence. 144: 70-7. PMID 25193717 DOI: 10.1016/j.drugalcdep.2014.08.008  1
2014 Schmaal L, Goudriaan AE, Joos L, Dom G, Pattij T, van den Brink W, Veltman DJ. Neural substrates of impulsive decision making modulated by modafinil in alcohol-dependent patients. Psychological Medicine. 44: 2787-98. PMID 25066449 DOI: 10.1017/S0033291714000312  1
2014 van Holst RJ, Clark L, Veltman DJ, van den Brink W, Goudriaan AE. Enhanced striatal responses during expectancy coding in alcohol dependence. Drug and Alcohol Dependence. 142: 204-8. PMID 25012896 DOI: 10.1016/j.drugalcdep.2014.06.019  1
2014 Derks EM, Vink JM, Willemsen G, van den Brink W, Boomsma DI. Genetic and environmental influences on the relationship between adult ADHD symptoms and self-reported problem drinking in 6024 Dutch twins. Psychological Medicine. 44: 2673-83. PMID 24957628 DOI: 10.1017/S0033291714000361  1
2014 Kräplin A, Bühringer G, Oosterlaan J, van den Brink W, Goschke T, Goudriaan AE. Dimensions and disorder specificity of impulsivity in pathological gambling. Addictive Behaviors. 39: 1646-51. PMID 24930455 DOI: 10.1016/j.addbeh.2014.05.021  1
2014 Vanes LD, van Holst RJ, Jansen JM, van den Brink W, Oosterlaan J, Goudriaan AE. Contingency learning in alcohol dependence and pathological gambling: learning and unlearning reward contingencies. Alcoholism, Clinical and Experimental Research. 38: 1602-10. PMID 24821534 DOI: 10.1111/acer.12393  1
2014 Tuithof M, ten Have M, van den Brink W, Vollebergh W, de Graaf R. Alcohol consumption and symptoms as predictors for relapse of DSM-5 alcohol use disorder. Drug and Alcohol Dependence. 140: 85-91. PMID 24793368 DOI: 10.1016/j.drugalcdep.2014.03.035  1
2014 van de Giessen E, Celik F, Schweitzer DH, van den Brink W, Booij J. Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesity. Journal of Psychopharmacology (Oxford, England). 28: 866-73. PMID 24785761 DOI: 10.1177/0269881114531664  1
2014 van den Berg JF, Hermes JS, van den Brink W, Blanken P, Kist N, Kok RM. Physical and mental health and social functioning in older alcohol-dependent inpatients: the role of age of onset. European Addiction Research. 20: 226-32. PMID 24776814 DOI: 10.1159/000357322  1
2014 van den Brink W, Mann K, Gual A, Aubin HJ. Wim van den Brink and colleagues reply to Des Spence and Alain Braillon. Bmj (Clinical Research Ed.). 348: g2605. PMID 24711667 DOI: 10.1136/bmj.g2605  1
2014 Crunelle CL, van den Brink W, Dom G, Booij J. Dopamine transporter occupancy by methylphenidate and impulsivity in adult ADHD. The British Journal of Psychiatry : the Journal of Mental Science. 204: 486-7. PMID 24676965 DOI: 10.1192/bjp.bp.113.132977  1
2014 van Zaane J, van de Ven PM, Draisma S, Smit JH, Nolen WA, van den Brink W. Effect of alcohol use on the course of bipolar disorder: one-year follow-up study using the daily prospective Life Chart method. Bipolar Disorders. 16: 400-9. PMID 24673879 DOI: 10.1111/bdi.12191  1
2014 van den Brink W, Sørensen P, Torup L, Mann K, Gual A. Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study. Journal of Psychopharmacology (Oxford, England). 28: 733-44. PMID 24671340 DOI: 10.1177/0269881114527362  1
2014 Mattila T, Wohlfarth T, Koeter M, Storosum J, van den Brink W, de Haan L, Leufkens H, Denys D. Geographic variation in efficacy of atypical antipsychotics for the acute treatment of schizophrenia - an individual patient data meta-analysis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1067-77. PMID 24661547 DOI: 10.1016/j.euroneuro.2014.02.006  1
2014 Machielsen MW, Veltman DJ, van den Brink W, de Haan L. The effect of clozapine and risperidone on attentional bias in patients with schizophrenia and a cannabis use disorder: An fMRI study. Journal of Psychopharmacology (Oxford, England). 28: 633-642. PMID 24646809 DOI: 10.1177/0269881114527357  1
2014 van den Brink W. [Addictive behaviours from DSM-IV to DSM-5]. Tijdschrift Voor Psychiatrie. 56: 206-10. PMID 24643833  1
2014 Nuijten M, Blanken P, van den Brink W, Hendriks V. Treatment of crack-cocaine dependence with topiramate: a randomized controlled feasibility trial in The Netherlands. Drug and Alcohol Dependence. 138: 177-84. PMID 24629631 DOI: 10.1016/j.drugalcdep.2014.02.024  1
2014 van der Pol P, Liebregts N, Brunt T, van Amsterdam J, de Graaf R, Korf DJ, van den Brink W, van Laar M. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study. Addiction (Abingdon, England). 109: 1101-9. PMID 24628797 DOI: 10.1111/add.12508  1
2014 Cousijn J, Vingerhoets WA, Koenders L, de Haan L, van den Brink W, Wiers RW, Goudriaan AE. Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls. Addiction Biology. 19: 282-93. PMID 24589297 DOI: 10.1111/adb.12111  1
2014 Sjoerds Z, Luigjes J, van den Brink W, Denys D, Yücel M. The role of habits and motivation in human drug addiction: a reflection. Frontiers in Psychiatry. 5: 8. PMID 24523702 DOI: 10.3389/fpsyt.2014.00008  1
2014 Boschloo L, van den Brink W, Penninx BW. Does self-medication predict the persistence or rather the recurrence of alcohol dependence? Jama Psychiatry. 71: 205. PMID 24500625 DOI: 10.1001/jamapsychiatry.2013.2985  0.96
2014 Crunelle CL, Kaag AM, van Wingen G, van den Munkhof HE, Homberg JR, Reneman L, van den Brink W. Reduced frontal brain volume in non-treatment-seeking cocaine-dependent individuals: exploring the role of impulsivity, depression, and smoking. Frontiers in Human Neuroscience. 8: 7. PMID 24478673 DOI: 10.3389/fnhum.2014.00007  1
2014 Roozen HG, Strietman M, Wiersema H, Meyers RJ, Lewinsohn PM, Feij JA, Greeven PG, Vingerhoets AJ, van den Brink W. Engagement of pleasant activities in patients with substance use disorders: a correlational study. Substance Abuse. 35: 254-61. PMID 24417592 DOI: 10.1080/08897077.2013.873760  1
2014 Sjoerds Z, van den Brink W, Beekman AT, Penninx BW, Veltman DJ. Cue reactivity is associated with duration and severity of alcohol dependence: an FMRI study. Plos One. 9: e84560. PMID 24400099 DOI: 10.1371/journal.pone.0084560  1
2014 van der Meer FJ, Meijer JH, Meijer CJ, van den Brink W, Velthorst E. Cognitive functioning associated with stimulant use in patients with non-affective psychosis, their unaffected siblings and healthy controls. Psychological Medicine. 44: 1901-11. PMID 24267407 DOI: 10.1017/S0033291713002626  1
2014 van de Glind G, Konstenius M, Koeter MW, van Emmerik-van Oortmerssen K, Carpentier PJ, Kaye S, Degenhardt L, Skutle A, Franck J, Bu ET, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapitány-Fövény M, ... ... van den Brink W, et al. Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria. Drug and Alcohol Dependence. 134: 158-66. PMID 24156882 DOI: 10.1016/j.drugalcdep.2013.09.026  1
2014 van Emmerik-van Oortmerssen K, van de Glind G, Koeter MW, Allsop S, Auriacombe M, Barta C, Bu ET, Burren Y, Carpentier PJ, Carruthers S, Casas M, Demetrovics Z, Dom G, Faraone SV, Fatseas M, ... ... van den Brink W, et al. Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. Addiction (Abingdon, England). 109: 262-72. PMID 24118292 DOI: 10.1111/add.12370  1
2014 Cousijn J, Wiers RW, Ridderinkhof KR, van den Brink W, Veltman DJ, Goudriaan AE. Effect of baseline cannabis use and working-memory network function on changes in cannabis use in heavy cannabis users: a prospective fMRI study. Human Brain Mapping. 35: 2470-82. PMID 24038570 DOI: 10.1002/hbm.22342  1
2014 Tuithof M, Ten Have M, van den Brink W, Vollebergh W, de Graaf R. The relationship between excessive alcohol consumption and alcohol use disorders according to DSM-IV and DSM-5. Alcoholism, Clinical and Experimental Research. 38: 249-56. PMID 24033529 DOI: 10.1111/acer.12248  1
2014 Sjoerds Z, van den Brink W, Beekman AT, Penninx BW, Veltman DJ. Response inhibition in alcohol-dependent patients and patients with depression/anxiety: a functional magnetic resonance imaging study. Psychological Medicine. 44: 1713-25. PMID 24016382 DOI: 10.1017/S0033291713002274  1
2014 Brunt TM, van Amsterdam JG, van den Brink W. GHB, GBL and 1,4-BD addiction. Current Pharmaceutical Design. 20: 4076-85. PMID 24001290 DOI: 10.2174/13816128113199990624  1
2014 Matthys F, Joostens P, Van Den Brink W, Sabbe B. ADHD in adults with SUD: A guideline for the diagnosis and treatment | ADHD bij verslaafden: richtlijn voor de diagnostiek en de behandeling Tijdschrift Voor Geneeskunde. 70: 1065-1069. DOI: 10.2143/TVG.70.18.2001694  1
2014 Matthys F, Stes S, van den Brink W, Joostens P, Möbius D, Tremmery S, Sabbe B. Guideline for Screening, Diagnosis and Treatment of ADHD in Adults with Substance Use Disorders International Journal of Mental Health and Addiction. 12: 629-647. DOI: 10.1007/s11469-014-9496-z  1
2013 Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Veltman DJ, Beekman AT, Penninx BW. Depressive and anxiety disorders predicting first incidence of alcohol use disorders: results of the Netherlands Study of Depression and Anxiety (NESDA). The Journal of Clinical Psychiatry. 74: 1233-40. PMID 24434092 DOI: 10.4088/JCP.12m08159  1
2013 Sjoerds Z, de Wit S, van den Brink W, Robbins TW, Beekman AT, Penninx BW, Veltman DJ. Behavioral and neuroimaging evidence for overreliance on habit learning in alcohol-dependent patients. Translational Psychiatry. 3: e337. PMID 24346135 DOI: 10.1038/tp.2013.107  1
2013 Dom G, van den Brink W. [Developments in pharmacotherapy: personalised pharmacotherapy?]. Tijdschrift Voor Psychiatrie. 55: 899-906. PMID 24242151  1
2013 Dom G, Schellekens A, Oude Voshaar R, van den Brink W. [Addiction research in the Low Countries: alive and kicking!]. Tijdschrift Voor Psychiatrie. 55: 817-9. PMID 24242139  1
2013 Cohn MD, Popma A, van den Brink W, Pape LE, Kindt M, van Domburgh L, Doreleijers TA, Veltman DJ. Fear conditioning, persistence of disruptive behavior and psychopathic traits: an fMRI study. Translational Psychiatry. 3: e319. PMID 24169638 DOI: 10.1038/tp.2013.89  1
2013 Joos L, Goudriaan AE, Schmaal L, van den Brink W, Sabbe BG, Dom G. Effect of modafinil on cognitive functions in alcohol dependent patients: a randomized, placebo-controlled trial. Journal of Psychopharmacology (Oxford, England). 27: 998-1006. PMID 24045883 DOI: 10.1177/0269881113503505  1
2013 van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M. Facilitators and barriers in treatment seeking for cannabis dependence. Drug and Alcohol Dependence. 133: 776-80. PMID 24035185 DOI: 10.1016/j.drugalcdep.2013.08.011  1
2013 van de Glind G, Van Emmerik-van Oortmerssen K, Carpentier PJ, Levin FR, Koeter MW, Barta C, Kaye S, Skutle A, Franck J, Konstenius M, Bu ET, Moggi F, Dom G, Demetrovics Z, Fatséas M, ... ... van den Brink W, et al. The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population. International Journal of Methods in Psychiatric Research. 22: 232-44. PMID 24022983 DOI: 10.1002/mpr.1397  1
2013 Liebregts N, van der Pol P, Van Laar M, de Graaf R, van den Brink W, Korf DJ. The Role of Study and Work in Cannabis Use and Dependence Trajectories among Young Adult Frequent Cannabis Users. Frontiers in Psychiatry. 4: 85. PMID 23950748 DOI: 10.3389/fpsyt.2013.00085  1
2013 Jansen JM, Daams JG, Koeter MW, Veltman DJ, van den Brink W, Goudriaan AE. Effects of non-invasive neurostimulation on craving: a meta-analysis. Neuroscience and Biobehavioral Reviews. 37: 2472-80. PMID 23916527 DOI: 10.1016/j.neubiorev.2013.07.009  1
2013 Tuithof M, Ten Have M, van den Brink W, Vollebergh W, de Graaf R. Predicting persistency of DSM-5 alcohol use disorder and examining drinking patterns of recently remitted individuals: a prospective general population study. Addiction (Abingdon, England). 108: 2091-9. PMID 23889861 DOI: 10.1111/add.12309  1
2013 van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M. Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. Drug and Alcohol Dependence. 133: 352-9. PMID 23886472 DOI: 10.1016/j.drugalcdep.2013.06.009  1
2013 van den Brink W, Aubin HJ, Bladström A, Torup L, Gual A, Mann K. Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: results from a subgroup analysis of two randomized controlled 6-month studies. Alcohol and Alcoholism (Oxford, Oxfordshire). 48: 570-8. PMID 23873853 DOI: 10.1093/alcalc/agt061  1
2013 van Amsterdam J, van den Brink W. Reduced-risk drinking as a viable treatment goal in problematic alcohol use and alcohol dependence. Journal of Psychopharmacology (Oxford, England). 27: 987-97. PMID 23824247 DOI: 10.1177/0269881113495320  1
2013 Matthys F, Joostens P, van den Brink W, Sabbe B. [Summary of the practice guideline for the diagnosis and treatment of ADHD in adolescents and adults with addictions]. Nederlands Tijdschrift Voor Geneeskunde. 157: A6025. PMID 23759179  1
2013 Crunelle CL, van den Brink W, Veltman DJ, van Emmerik-van Oortmerssen K, Dom G, Schoevers RA, Booij J. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1714-23. PMID 23731497 DOI: 10.1016/j.euroneuro.2013.05.002  1
2013 van Wingen GA, van den Brink W, Veltman DJ, Schmaal L, Dom G, Booij J, Crunelle CL. Reduced striatal brain volumes in non-medicated adult ADHD patients with comorbid cocaine dependence. Drug and Alcohol Dependence. 131: 198-203. PMID 23726981 DOI: 10.1016/j.drugalcdep.2013.05.007  1
2013 van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M. Reliability and validity of the Severity of Dependence Scale for detecting cannabis dependence in frequent cannabis users. International Journal of Methods in Psychiatric Research. 22: 138-43. PMID 23670783 DOI: 10.1002/mpr.1385  1
2013 van Emmerik-van Oortmerssen K, Vedel E, Koeter MW, de Bruijn K, Dekker JJ, van den Brink W, Schoevers RA. Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial. Bmc Psychiatry. 13: 132. PMID 23663651 DOI: 10.1186/1471-244X-13-132  1
2013 van de Glind G, van den Brink W, Koeter MW, Carpentier PJ, van Emmerik-van Oortmerssen K, Kaye S, Skutle A, Bu ET, Franck J, Konstenius M, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapitány-Fövény M, et al. Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug and Alcohol Dependence. 132: 587-96. PMID 23660242 DOI: 10.1016/j.drugalcdep.2013.04.010  1
2013 van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M. Validation of self-reported cannabis dose and potency: an ecological study. Addiction (Abingdon, England). 108: 1801-8. PMID 23627816 DOI: 10.1111/add.12226  1
2013 Gual A, He Y, Torup L, van den Brink W, Mann K. A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1432-42. PMID 23562264 DOI: 10.1016/j.euroneuro.2013.02.006  1
2013 van Amsterdam J, Pennings E, Brunt T, van den Brink W. Physical harm due to chronic substance use. Regulatory Toxicology and Pharmacology : Rtp. 66: 83-7. PMID 23542091 DOI: 10.1016/j.yrtph.2013.03.007  1
2013 van der Pol P, Liebregts N, de Graaf R, Ten Have M, Korf DJ, van den Brink W, van Laar M. Mental health differences between frequent cannabis users with and without dependence and the general population. Addiction (Abingdon, England). 108: 1459-69. PMID 23530710 DOI: 10.1111/add.12196  1
2013 Starcke K, van Holst RJ, van den Brink W, Veltman DJ, Goudriaan AE. Physiological and endocrine reactions to psychosocial stress in alcohol use disorders: duration of abstinence matters. Alcoholism, Clinical and Experimental Research. 37: 1343-50. PMID 23488992 DOI: 10.1111/acer.12103  1
2013 Figee M, Luigjes J, Smolders R, Valencia-Alfonso CE, van Wingen G, de Kwaasteniet B, Mantione M, Ooms P, de Koning P, Vulink N, Levar N, Droge L, van den Munckhof P, Schuurman PR, Nederveen A, ... van den Brink W, et al. Deep brain stimulation restores frontostriatal network activity in obsessive-compulsive disorder. Nature Neuroscience. 16: 386-7. PMID 23434914 DOI: 10.1038/nn.3344  1
2013 Schmaal L, Goudriaan AE, Joos L, Krüse AM, Dom G, van den Brink W, Veltman DJ. Modafinil modulates resting-state functional network connectivity and cognitive control in alcohol-dependent patients. Biological Psychiatry. 73: 789-95. PMID 23399373 DOI: 10.1016/j.biopsych.2012.12.025  1
2013 van Amsterdam J, Nutt D, van den Brink W. Generic legislation of new psychoactive drugs. Journal of Psychopharmacology (Oxford, England). 27: 317-24. PMID 23343598 DOI: 10.1177/0269881112474525  1
2013 Brunt TM, Koeter MW, Hertoghs N, van Noorden MS, van den Brink W. Sociodemographic and substance use characteristics of γ hydroxybutyrate (GHB) dependent inpatients and associations with dependence severity. Drug and Alcohol Dependence. 131: 316-9. PMID 23332440 DOI: 10.1016/j.drugalcdep.2012.12.023  1
2013 van Amsterdam J, van den Brink W. The high harm score of alcohol. Time for drug policy to be revisited? Journal of Psychopharmacology (Oxford, England). 27: 248-55. PMID 23325370 DOI: 10.1177/0269881112472559  1
2013 Merkx MJ, Schippers GM, Koeter MW, Vuijk PJ, Poch M, Kronemeijer H, van den Brink W. Predictive validity of treatment allocation guidelines on drinking outcome in alcohol-dependent patients. Addictive Behaviors. 38: 1691-8. PMID 23254220 DOI: 10.1016/j.addbeh.2012.09.011  1
2013 Mann K, Bladström A, Torup L, Gual A, van den Brink W. Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene. Biological Psychiatry. 73: 706-13. PMID 23237314 DOI: 10.1016/j.biopsych.2012.10.020  1
2013 Schouw ML, De Ruiter MB, Kaag AM, van den Brink W, Lindauer RJ, Reneman L. Dopaminergic dysfunction in abstinent dexamphetamine users: results from a pharmacological fMRI study using a reward anticipation task and a methylphenidate challenge. Drug and Alcohol Dependence. 130: 52-60. PMID 23142493 DOI: 10.1016/j.drugalcdep.2012.10.010  1
2013 Joos L, Goudriaan AE, Schmaal L, Fransen E, van den Brink W, Sabbe BG, Dom G. Effect of modafinil on impulsivity and relapse in alcohol dependent patients: a randomized, placebo-controlled trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 948-55. PMID 23141152 DOI: 10.1016/j.euroneuro.2012.10.004  1
2013 Joos L, Goudriaan AE, Schmaal L, De Witte NA, Van den Brink W, Sabbe BG, Dom G. The relationship between impulsivity and craving in alcohol dependent patients. Psychopharmacology. 226: 273-83. PMID 23096771 DOI: 10.1007/s00213-012-2905-8  1
2013 Sjoerds Z, van Tol MJ, van den Brink W, van der Wee NJ, Aleman A, Beekman AT, Penninx BW, Veltman DJ. Family history of alcohol dependence modulates functional neurophysiology in mood/anxiety disorders. Psychological Medicine. 43: 1487-97. PMID 23036336 DOI: 10.1017/S003329171200222X  1
2013 Crunelle CL, Veltman DJ, van Emmerik-van Oortmerssen K, Booij J, van den Brink W. Impulsivity in adult ADHD patients with and without cocaine dependence. Drug and Alcohol Dependence. 129: 18-24. PMID 23026814 DOI: 10.1016/j.drugalcdep.2012.09.006  1
2013 Joos L, Schmaal L, Goudriaan AE, Fransen E, Van den Brink W, Sabbe BG, Dom G. Age of onset and neuropsychological functioning in alcohol dependent inpatients. Alcoholism, Clinical and Experimental Research. 37: 407-16. PMID 23025636 DOI: 10.1111/j.1530-0277.2012.01949.x  1
2013 Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Beekman AT, Penninx BW. The role of negative emotionality and impulsivity in depressive/anxiety disorders and alcohol dependence. Psychological Medicine. 43: 1241-53. PMID 23020956 DOI: 10.1017/S0033291712002152  1
2013 Cousijn J, Wiers RW, Ridderinkhof KR, van den Brink W, Veltman DJ, Porrino LJ, Goudriaan AE. Individual differences in decision making and reward processing predict changes in cannabis use: a prospective functional magnetic resonance imaging study. Addiction Biology. 18: 1013-23. PMID 22994937 DOI: 10.1111/j.1369-1600.2012.00498.x  1
2013 Corazza O, Demetrovics Z, van den Brink W, Schifano F. 'Legal highs' an inappropriate term for 'Novel Psychoactive Drugs' in drug prevention and scientific debate. The International Journal On Drug Policy. 24: 82-3. PMID 22883544 DOI: 10.1016/j.drugpo.2012.06.005  1
2013 van de Giessen E, la Fleur SE, Eggels L, de Bruin K, van den Brink W, Booij J. High fat/carbohydrate ratio but not total energy intake induces lower striatal dopamine D2/3 receptor availability in diet-induced obesity. International Journal of Obesity (2005). 37: 754-7. PMID 22868829 DOI: 10.1038/ijo.2012.128  1
2013 Schmaal L, Joos L, Koeleman M, Veltman DJ, van den Brink W, Goudriaan AE. Effects of modafinil on neural correlates of response inhibition in alcohol-dependent patients. Biological Psychiatry. 73: 211-8. PMID 22858150 DOI: 10.1016/j.biopsych.2012.06.032  1
2013 Goudriaan AE, Veltman DJ, van den Brink W, Dom G, Schmaal L. Neurophysiological effects of modafinil on cue-exposure in cocaine dependence: a randomized placebo-controlled cross-over study using pharmacological fMRI. Addictive Behaviors. 38: 1509-17. PMID 22591950 DOI: 10.1016/j.addbeh.2012.04.006  1
2013 Sjoerds Z, Van Tol MJ, Van den Brink W, Van der Wee NJ, Van Buchem MA, Aleman A, Penninx BW, Veltman DJ. Family history of alcohol dependence and gray matter abnormalities in non-alcoholic adults. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 14: 565-73. PMID 22283466 DOI: 10.3109/15622975.2011.640942  1
2013 Cousijn J, Goudriaan AE, Ridderinkhof KR, van den Brink W, Veltman DJ, Wiers RW. Neural responses associated with cue-reactivity in frequent cannabis users. Addiction Biology. 18: 570-80. PMID 22264344 DOI: 10.1111/j.1369-1600.2011.00417.x  1
2013 Crunelle CL, van de Giessen E, Schulz S, Vanderschuren LJ, de Bruin K, van den Brink W, Booij J. Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability. Addiction Biology. 18: 908-11. PMID 21955259 DOI: 10.1111/j.1369-1600.2011.00369.x  1
2013 Kuyck WGE, de Beurs E, Barendregt M, van den Brink W. Psychometric Evaluation of the Dutch Version of the Impulsive/Premeditated Aggression Scale (IPAS) in Male and Female Prisoners International Journal of Forensic Mental Health. 12: 172-179. DOI: 10.1080/14999013.2013.819396  1
2013 Van Den Brink W. 'As needed' nalmefene: A new treatment for alcohol dependence | Nalmefeen 'zo nodig': Een nieuwe behandeling voor alcoholafhankelijkheid Tijdschrift Voor Psychiatrie. 55: 294-295.  1
2012 van Amsterdam JG, Brunt TM, McMaster MT, Niesink R, van Noorden MS, van den Brink W. [Cognitive impairment due to intensive use and overdoses of gammahydroxybutyric acid (GHB)]. Tijdschrift Voor Psychiatrie. 54: 1001-10. PMID 23250641  1
2012 Schierenberg A, van Amsterdam J, van den Brink W, Goudriaan AE. Efficacy of contingency management for cocaine dependence treatment: a review of the evidence. Current Drug Abuse Reviews. 5: 320-31. PMID 23244344  1
2012 van Holst RJ, van der Meer JN, McLaren DG, van den Brink W, Veltman DJ, Goudriaan AE. Interactions between affective and cognitive processing systems in problematic gamblers: a functional connectivity study. Plos One. 7: e49923. PMID 23209619 DOI: 10.1371/journal.pone.0049923  1
2012 Schmaal L, Goudriaan AE, van der Meer J, van den Brink W, Veltman DJ. The association between cingulate cortex glutamate concentration and delay discounting is mediated by resting state functional connectivity. Brain and Behavior. 2: 553-62. PMID 23139901 DOI: 10.1002/brb3.74  1
2012 van den Brink W, Schippers GM. [Staging and profiling in addication]. Tijdschrift Voor Psychiatrie. 54: 941-8. PMID 23138621  1
2012 Dekker N, Koeter M, Van Den Brink W. Craving for cannabis in patients with psychotic disorder, their non-affected siblings and healthy controls: psychometric analysis of the obsessive compulsive drug use scale. International Journal of Methods in Psychiatric Research. 21: 286-300. PMID 22961922 DOI: 10.1002/mpr.1362  1
2012 Cousijn J, Goudriaan AE, Ridderinkhof KR, van den Brink W, Veltman DJ, Wiers RW. Approach-bias predicts development of cannabis problem severity in heavy cannabis users: results from a prospective FMRI study. Plos One. 7: e42394. PMID 22957019 DOI: 10.1371/journal.pone.0042394  1
2012 Crunelle CL, Veltman DJ, Booij J, Emmerik-van Oortmerssen K, van den Brink W. Substrates of neuropsychological functioning in stimulant dependence: a review of functional neuroimaging research. Brain and Behavior. 2: 499-523. PMID 22950052 DOI: 10.1002/brb3.65  1
2012 van Holst RJ, Veltman DJ, van den Brink W, Goudriaan AE. Right on cue? Striatal reactivity in problem gamblers. Biological Psychiatry. 72: e23-4. PMID 22795970 DOI: 10.1016/j.biopsych.2012.06.017  1
2012 Reneman L, de Win MM, Booij J, van den Brink W, den Heeten GJ, Freling N, Majoie CB. Incidental head and neck findings on MRI in young healthy volunteers: prevalence and clinical implications. Ajnr. American Journal of Neuroradiology. 33: 1971-4. PMID 22723061 DOI: 10.3174/ajnr.A3217  1
2012 Ingenhoven TJ, Duivenvoorden HJ, Passchier J, van den Brink W. Treatment duration and premature termination of psychotherapy in personality disorders: predictive performance of psychodynamic personality functioning. Journal of Psychiatric Practice. 18: 172-86. PMID 22617082 DOI: 10.1097/01.pra.0000415074.43744.29  1
2012 Broos N, Schmaal L, Wiskerke J, Kostelijk L, Lam T, Stoop N, Weierink L, Ham J, de Geus EJ, Schoffelmeer AN, van den Brink W, Veltman DJ, de Vries TJ, Pattij T, Goudriaan AE. The relationship between impulsive choice and impulsive action: a cross-species translational study. Plos One. 7: e36781. PMID 22574225 DOI: 10.1371/journal.pone.0036781  1
2012 Kuipers MA, van Poppel MN, van den Brink W, Wingen M, Kunst AE. The association between neighborhood disorder, social cohesion and hazardous alcohol use: a national multilevel study. Drug and Alcohol Dependence. 126: 27-34. PMID 22572208 DOI: 10.1016/j.drugalcdep.2012.04.008  1
2012 Schmaal L, Veltman DJ, Nederveen A, van den Brink W, Goudriaan AE. N-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2143-52. PMID 22549117 DOI: 10.1038/npp.2012.66  1
2012 van Holst RJ, van Holstein M, van den Brink W, Veltman DJ, Goudriaan AE. Response inhibition during cue reactivity in problem gamblers: an fMRI study. Plos One. 7: e30909. PMID 22479305 DOI: 10.1371/journal.pone.0030909  1
2012 Dekker N, Meijer J, Koeter M, van den Brink W, van Beveren N, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I. Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender. Psychological Medicine. 42: 1903-11. PMID 22452790 DOI: 10.1017/S0033291712000062  1
2012 van Amsterdam JG, van Laar M, Brunt TM, van den Brink W. Risk assessment of gamma-hydroxybutyric acid (GHB) in the Netherlands. Regulatory Toxicology and Pharmacology : Rtp. 63: 55-63. PMID 22440552 DOI: 10.1016/j.yrtph.2012.03.005  1
2012 van de Giessen E, Nimgaonkar VL, Watson AM, Kodavali C, Baas F, Tanck MW, de Win MM, van den Brink W, Booij J. Association tests of striatal DAT availability and SNPs that impact a novel splice variant in the DAT gene. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 839. PMID 22427685 DOI: 10.2967/jnumed.111.100271  1
2012 Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Beekman AT, Penninx BW. Predictors of the 2-year recurrence and persistence of alcohol dependence. Addiction (Abingdon, England). 107: 1639-40. PMID 22372473 DOI: 10.1111/j.1360-0443.2012.03860.x  1
2012 van Holst RJ, Veltman DJ, Büchel C, van den Brink W, Goudriaan AE. Distorted expectancy coding in problem gambling: is the addictive in the anticipation? Biological Psychiatry. 71: 741-8. PMID 22342105 DOI: 10.1016/j.biopsych.2011.12.030  1
2012 van Zaane J, van den Berg B, Draisma S, Nolen WA, van den Brink W. Screening for bipolar disorders in patients with alcohol or substance use disorders: performance of the mood disorder questionnaire. Drug and Alcohol Dependence. 124: 235-41. PMID 22341144 DOI: 10.1016/j.drugalcdep.2012.01.018  1
2012 Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Veltman DJ, Beekman AT, Penninx BW. Alcohol use disorders and the course of depressive and anxiety disorders. The British Journal of Psychiatry : the Journal of Mental Science. 200: 476-84. PMID 22322459 DOI: 10.1192/bjp.bp.111.097550  1
2012 van Dijk D, Koeter MW, Hijman R, Kahn RS, van den Brink W. Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study. Schizophrenia Research. 137: 50-7. PMID 22313726 DOI: 10.1016/j.schres.2012.01.016  1
2012 van de Giessen E, la Fleur SE, de Bruin K, van den Brink W, Booij J. Free-choice and no-choice high-fat diets affect striatal dopamine D2/3 receptor availability, caloric intake, and adiposity. Obesity (Silver Spring, Md.). 20: 1738-40. PMID 22307070 DOI: 10.1038/oby.2012.17  1
2012 Valencia-Alfonso CE, Luigjes J, Smolders R, Cohen MX, Levar N, Mazaheri A, van den Munckhof P, Schuurman PR, van den Brink W, Denys D. Effective deep brain stimulation in heroin addiction: a case report with complementary intracranial electroencephalogram. Biological Psychiatry. 71: e35-7. PMID 22281120 DOI: 10.1016/j.biopsych.2011.12.013  1
2012 van Holst RJ, de Ruiter MB, van den Brink W, Veltman DJ, Goudriaan AE. A voxel-based morphometry study comparing problem gamblers, alcohol abusers, and healthy controls. Drug and Alcohol Dependence. 124: 142-8. PMID 22270405 DOI: 10.1016/j.drugalcdep.2011.12.025  1
2012 Crunelle CL, de Wit TC, de Bruin K, Ramakers RM, van der Have F, Beekman FJ, van den Brink W, Booij J. Varenicline increases in vivo striatal dopamine D2/3 receptor binding: an ultra-high-resolution pinhole [123I]IBZM SPECT study in rats. Nuclear Medicine and Biology. 39: 640-4. PMID 22261145 DOI: 10.1016/j.nucmedbio.2011.11.006  1
2012 van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W, Smit F, Crunelle CL, Swets M, Schoevers RA. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug and Alcohol Dependence. 122: 11-9. PMID 22209385 DOI: 10.1016/j.drugalcdep.2011.12.007  1
2012 Veldhuis J, Dieleman JP, Wohlfarth T, Storosum JG, van Den Brink W, Sturkenboom MC, Denys D. Incidence and prevalence of "diagnosed OCD" in a primary care, treatment seeking, population. International Journal of Psychiatry in Clinical Practice. 16: 85-92. PMID 22122660 DOI: 10.3109/13651501.2011.617454  1
2012 Tuithof M, ten Have M, van den Brink W, Vollebergh W, de Graaf R. The role of conduct disorder in the association between ADHD and alcohol use (disorder). Results from the Netherlands Mental Health Survey and Incidence Study-2. Drug and Alcohol Dependence. 123: 115-21. PMID 22118715 DOI: 10.1016/j.drugalcdep.2011.10.030  1
2012 Brunt TM, Koeter MW, Niesink RJ, van den Brink W. Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users. Psychopharmacology. 220: 751-62. PMID 21993879 DOI: 10.1007/s00213-011-2529-4  0.64
2012 Cousijn J, Wiers RW, Ridderinkhof KR, van den Brink W, Veltman DJ, Goudriaan AE. Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls. Neuroimage. 59: 3845-51. PMID 21982932 DOI: 10.1016/j.neuroimage.2011.09.046  1
2012 Luigjes J, van den Brink W, Feenstra M, van den Munckhof P, Schuurman PR, Schippers R, Mazaheri A, De Vries TJ, Denys D. Deep brain stimulation in addiction: a review of potential brain targets. Molecular Psychiatry. 17: 572-83. PMID 21931318 DOI: 10.1038/mp.2011.114  1
2012 de Ruiter MB, Oosterlaan J, Veltman DJ, van den Brink W, Goudriaan AE. Similar hyporesponsiveness of the dorsomedial prefrontal cortex in problem gamblers and heavy smokers during an inhibitory control task. Drug and Alcohol Dependence. 121: 81-9. PMID 21893386 DOI: 10.1016/j.drugalcdep.2011.08.010  1
2012 van de Giessen E, de Bruin K, la Fleur SE, van den Brink W, Booij J. Triple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 290-9. PMID 21889317 DOI: 10.1016/j.euroneuro.2011.07.015  1
2012 Boschloo L, van den Brink W, Penninx BW, Wall MM, Hasin DS. Alcohol-use disorder severity predicts first-incidence of depressive disorders. Psychological Medicine. 42: 695-703. PMID 21867593 DOI: 10.1017/S0033291711001681  1
2012 Blanken P, Hendriks VM, Koeter MW, van Ree JM, van den Brink W. Craving and illicit heroin use among patients in heroin-assisted treatment. Drug and Alcohol Dependence. 120: 74-80. PMID 21782351 DOI: 10.1016/j.drugalcdep.2011.06.025  1
2012 Boschloo L, Vogelzangs N, Van Den Brink W, Smit JH, Veltman DJ, Beekman ATF, Penninx BWJH. Authors' reply: British Journal of Psychiatry. 201: 326-327. DOI: 10.1192/bjp.201.4.326a  1
2012 Nuijten M, Blanken P, Van Der Hoorn B, Van Den Brink W, Hendriks V. A randomised controlled trial of outpatient versus inpatient integrated treatment of dual diagnosis patients: A failed but informative study Mental Health and Substance Use: Dual Diagnosis. 5: 132-147. DOI: 10.1080/17523281.2011.628947  1
2011 Luigjes J, Mantione M, van den Brink W, Schuurman PR, van den Munckhof P, Denys D. Deep brain stimulation increases impulsivity in two patients with obsessive-compulsive disorder. International Clinical Psychopharmacology. 26: 338-40. PMID 21857527 DOI: 10.1097/YIC.0b013e32834af505  1
2011 Nuijten M, Blanken P, van den Brink W, Hendriks V. Cocaine Addiction Treatments to improve Control and reduce Harm (CATCH): new pharmacological treatment options for crack-cocaine dependence in the Netherlands. Bmc Psychiatry. 11: 135. PMID 21854580 DOI: 10.1186/1471-244X-11-135  0.6
2011 van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M. The Dutch Cannabis Dependence (CanDep) study on the course of frequent cannabis use and dependence: objectives, methods and sample characteristics. International Journal of Methods in Psychiatric Research. 20: 169-81. PMID 21815231 DOI: 10.1002/mpr.345  0.64
2011 Blom RM, Koeter M, van den Brink W, de Graaf R, Ten Have M, Denys D. Co-occurrence of obsessive-compulsive disorder and substance use disorder in the general population. Addiction (Abingdon, England). 106: 2178-85. PMID 21714825 DOI: 10.1111/j.1360-0443.2011.03559.x  1
2011 Schmaal L, Berk L, Hulstijn KP, Cousijn J, Wiers RW, van den Brink W. Efficacy of N-acetylcysteine in the treatment of nicotine dependence: a double-blind placebo-controlled pilot study. European Addiction Research. 17: 211-6. PMID 21606648 DOI: 10.1159/000327682  1
2011 Soyka M, Kranzler HR, van den Brink W, Krystal J, Möller HJ, Kasper S. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 12: 160-87. PMID 21486104 DOI: 10.3109/15622975.2011.561872  1
2011 Buster MC, van den Brink W, van Brussel GH, van Ree JM. Influence of treatment with inhalable heroin on pulmonary function. European Addiction Research. 17: 136-8. PMID 21422758 DOI: 10.1159/000324482  1
2011 van de Giessen E, Groot PF, Booij J, van den Brink W, Veltman DJ, Nederveen AJ. Functional MR imaging on an open 1T MR imaging system: exploiting the advantages of an open MR imaging system for functional MR imaging. Ajnr. American Journal of Neuroradiology. 32: 903-7. PMID 21330391 DOI: 10.3174/ajnr.A2383  1
2011 Boschloo L, Vogelzangs N, Licht CM, Vreeburg SA, Smit JH, van den Brink W, Veltman DJ, de Geus EJ, Beekman AT, Penninx BW. Heavy alcohol use, rather than alcohol dependence, is associated with dysregulation of the hypothalamic-pituitary-adrenal axis and the autonomic nervous system. Drug and Alcohol Dependence. 116: 170-6. PMID 21330066 DOI: 10.1016/j.drugalcdep.2010.12.006  1
2011 Oudejans SC, Schippers GM, Schramade MH, Koeter MW, van den Brink W. Measuring the learning capacity of organisations: development and factor analysis of the Questionnaire for Learning Organizations. Bmj Quality & Safety. 20: 307-13. PMID 21292691 DOI: 10.1136/bmjqs.2010.042556  0.64
2011 van Amsterdam J, Opperhuizen A, van den Brink W. Harm potential of magic mushroom use: a review. Regulatory Toxicology and Pharmacology : Rtp. 59: 423-9. PMID 21256914 DOI: 10.1016/j.yrtph.2011.01.006  0.68
2011 Boschloo L, Vogelzangs N, Smit JH, van den Brink W, Veltman DJ, Beekman AT, Penninx BW. Comorbidity and risk indicators for alcohol use disorders among persons with anxiety and/or depressive disorders: findings from the Netherlands Study of Depression and Anxiety (NESDA). Journal of Affective Disorders. 131: 233-42. PMID 21247636 DOI: 10.1016/j.jad.2010.12.014  1
2011 Merkx MJ, Schippers GM, Koeter MW, Vuijk PJ, Oudejans SC, Stam RK, van den Brink W. Guidelines for allocating outpatient alcohol abusers to levels of care: Predictive validity. Addictive Behaviors. 36: 570-5. PMID 21236585 DOI: 10.1016/j.addbeh.2010.12.021  0.64
2011 Crunelle CL, Schulz S, de Bruin K, Miller ML, van den Brink W, Booij J. Dose-dependent and sustained effects of varenicline on dopamine D2/3 receptor availability in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 21: 205-10. PMID 21130610 DOI: 10.1016/j.euroneuro.2010.11.001  1
2011 Luijten M, Veltman DJ, van den Brink W, Hester R, Field M, Smits M, Franken IH. Neurobiological substrate of smoking-related attentional bias. Neuroimage. 54: 2374-81. PMID 20932921 DOI: 10.1016/j.neuroimage.2010.09.064  1
2011 Sekar V, Tomaka F, Lefebvre E, De Pauw M, Vangeneugden T, van den Brink W, Hoetelmans R. Pharmacokinetic interactions between darunavir/ritonavir and opioid maintenance therapy using methadone or buprenorphine/naloxone. Journal of Clinical Pharmacology. 51: 271-8. PMID 20421512 DOI: 10.1177/0091270010365558  1
2011 Burke SM, van de Giessen E, de Win M, Schilt T, van Herk M, van den Brink W, Booij J. Serotonin and dopamine transporters in relation to neuropsychological functioning, personality traits and mood in young adult healthy subjects. Psychological Medicine. 41: 419-29. PMID 20367893 DOI: 10.1017/S0033291710000486  1
2010 van Amsterdam J, van den Brink W. Ranking of drugs: a more balanced risk-assessment. Lancet. 376: 1524-5. PMID 21036391 DOI: 10.1016/S0140-6736(10)62000-4  0.68
2010 Goudriaan AE, de Ruiter MB, van den Brink W, Oosterlaan J, Veltman DJ. Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study. Addiction Biology. 15: 491-503. PMID 20840335 DOI: 10.1111/j.1369-1600.2010.00242.x  1
2010 van Nimwegen-Campailla L, van Beveren N, Laan W, van den Brink W, Linszen D, de Haan L. Effect of early dysphoric response and cannabis use on discontinuation of olanzapine or risperidone in patients with early psychosis. Pharmacopsychiatry. 43: 281. PMID 20839158 DOI: 10.1055/s-0030-1263172  1
2010 van Holst RJ, van den Brink W, Veltman DJ, Goudriaan AE. Brain imaging studies in pathological gambling. Current Psychiatry Reports. 12: 418-25. PMID 20676945 DOI: 10.1007/s11920-010-0141-7  1
2010 Koeter MW, van den Brink W, Lehert P. Effect of early and late compliance on the effectiveness of acamprosate in the treatment of alcohol dependence. Journal of Substance Abuse Treatment. 39: 218-26. PMID 20627222 DOI: 10.1016/j.jsat.2010.06.002  0.64
2010 van Amsterdam J, Opperhuizen A, Koeter M, van den Brink W. Ranking the harm of alcohol, tobacco and illicit drugs for the individual and the population. European Addiction Research. 16: 202-7. PMID 20606445 DOI: 10.1159/000317249  0.84
2010 Boschloo L, Vogelzangs N, Smit JH, van den Brink W, Veltman DJ, Beekman AT, Penninx BW. The performance of the Alcohol Use Disorder Identification Test (AUDIT) in detecting alcohol abuse and dependence in a population of depressed or anxious persons. Journal of Affective Disorders. 126: 441-6. PMID 20537398 DOI: 10.1016/j.jad.2010.04.019  1
2010 Blanken P, van den Brink W, Hendriks VM, Huijsman IA, Klous MG, Rook EJ, Wakelin JS, Barendrecht C, Beijnen JH, van Ree JM. Heroin-assisted treatment in the Netherlands: History, findings, and international context. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: S105-58. PMID 20362236 DOI: 10.1016/S0924-977X(10)70001-8  1
2010 Schippers GM, Broekman TG, Buchholz A, Koeter MW, van den Brink W. Measurements in the Addictions for Triage and Evaluation (MATE): an instrument based on the World Health Organization family of international classifications. Addiction (Abingdon, England). 105: 862-71. PMID 20331557 DOI: 10.1111/j.1360-0443.2009.02889.x  0.64
2010 van Zaane J, van den Brink W, Draisma S, Smit JH, Nolen WA. The effect of moderate and excessive alcohol use on the course and outcome of patients with bipolar disorders: a prospective cohort study. The Journal of Clinical Psychiatry. 71: 885-93. PMID 20122372 DOI: 10.4088/JCP.09m05079gry  1
2010 Crunelle CL, Miller ML, Booij J, van den Brink W. The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 69-79. PMID 19959340 DOI: 10.1016/j.euroneuro.2009.11.001  1
2010 Blanken P, Hendriks VM, van Ree JM, van den Brink W. Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands. Addiction (Abingdon, England). 105: 300-8. PMID 19922517 DOI: 10.1111/j.1360-0443.2009.02754.x  1
2010 Schilt T, Koeter MW, Smal JP, Gouwetor MN, van den Brink W, Schmand B. Long-term neuropsychological effects of ecstasy in middle-aged ecstasy/polydrug users. Psychopharmacology. 207: 583-91. PMID 19823808 DOI: 10.1007/s00213-009-1688-z  1
2010 Sizoo B, van den Brink W, Koeter M, Gorissen van Eenige M, van Wijngaarden-Cremers P, van der Gaag RJ. Treatment seeking adults with autism or ADHD and co-morbid substance use disorder: prevalence, risk factors and functional disability. Drug and Alcohol Dependence. 107: 44-50. PMID 19786328 DOI: 10.1016/j.drugalcdep.2009.09.003  0.84
2010 van Holst RJ, van den Brink W, Veltman DJ, Goudriaan AE. Why gamblers fail to win: a review of cognitive and neuroimaging findings in pathological gambling. Neuroscience and Biobehavioral Reviews. 34: 87-107. PMID 19632269 DOI: 10.1016/j.neubiorev.2009.07.007  1
2009 Dols A, van den Brink W, Eikelenboom P. [Vaccinations in psychiatry]. Tijdschrift Voor Psychiatrie. 51: 751-9. PMID 19821243  1
2009 Wohlfarth T, Linszen D, Van Den Brink W. Blinding in clozapine trials: a problem and a potential solution. International Journal of Methods in Psychiatric Research. 18: 185-8. PMID 19701925 DOI: 10.1002/mpr.291  0.48
2009 Crunelle CL, Miller ML, de Bruin K, van den Brink W, Booij J. Varenicline increases striatal dopamine D(2/3) receptor binding in rats. Addiction Biology. 14: 500-2. PMID 19650815 DOI: 10.1111/j.1369-1600.2009.00168.x  1
2009 Oudejans SC, Schippers GM, Merkx MJ, Schramade MH, Koeter MW, van den Brink W. Feasibility and validity of low-budget telephonic follow-up interviews in routine outcome monitoring of substance abuse treatment. Addiction (Abingdon, England). 104: 1138-46. PMID 19563559 DOI: 10.1111/j.1360-0443.2009.02593.x  0.64
2009 Ooteman W, Naassila M, Koeter MW, Verheul R, Schippers GM, Houchi H, Daoust M, van den Brink W. Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators. Addiction Biology. 14: 328-37. PMID 19523047 DOI: 10.1111/j.1369-1600.2009.00159.x  0.64
2009 Couwenbergh C, Van Der Gaag RJ, Koeter M, De Ruiter C, Van den Brink W. Screening for substance abuse among adolescents validity of the CAGE-AID in youth mental health care. Substance Use & Misuse. 44: 823-34. PMID 19444724 DOI: 10.1080/10826080802484264  0.84
2009 Sizoo BB, van den Brink W, Gorissen-van Eenige M, Koeter MW, van Wijngaarden-Cremers PJ, van der Gaag RJ. Using the Autism-spectrum quotient to discriminate Autism Spectrum Disorder from ADHD in adult patients with and without comorbid Substance Use Disorder. Journal of Autism and Developmental Disorders. 39: 1291-7. PMID 19396535 DOI: 10.1007/s10803-009-0743-2  0.64
2009 Vanderschuren LJ, Matthys W, van den Brink W. [Impulse regulation disturbances. Physiopathology and treatment]. Nederlands Tijdschrift Voor Geneeskunde. 153: 240-3. PMID 19271444  1
2009 van de Giessen E, de Win MM, Tanck MW, van den Brink W, Baas F, Booij J. Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 45-52. PMID 19091889 DOI: 10.2967/jnumed.108.053652  1
2009 Schilt T, Goudriaan AE, Koeter MW, van den Brink W, Schmand B. Decision making as a predictor of first ecstasy use: a prospective study. Psychopharmacology. 203: 519-27. PMID 19020868 DOI: 10.1007/s00213-008-1398-y  1
2009 de Ruiter MB, Veltman DJ, Goudriaan AE, Oosterlaan J, Sjoerds Z, van den Brink W. Response perseveration and ventral prefrontal sensitivity to reward and punishment in male problem gamblers and smokers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1027-38. PMID 18830241 DOI: 10.1038/npp.2008.175  1
2009 Zijlstra F, Veltman DJ, Booij J, van den Brink W, Franken IH. Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males. Drug and Alcohol Dependence. 99: 183-92. PMID 18823721 DOI: 10.1016/j.drugalcdep.2008.07.012  1
2008 de Win MM, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, den Heeten GJ, van den Brink W. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain : a Journal of Neurology. 131: 2936-45. PMID 18842607 DOI: 10.1093/brain/awn255  1
2008 de Win MM, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, Ramsey NF, Heeten GJ, van den Brink W. Neurotoxic effects of ecstasy on the thalamus. The British Journal of Psychiatry : the Journal of Mental Science. 193: 289-96. PMID 18827290 DOI: 10.1192/bjp.bp.106.035089  1
2008 van Nimwegen LJ, de Haan L, van Beveren NJ, van der Helm M, van den Brink W, Linszen D. Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 53: 400-5. PMID 18616861  0.6
2008 Duits N, Doreleijers TA, van den Brink W. Assessment of violence risk in youth for juvenile court: relevant factors for clinical judgment. International Journal of Law and Psychiatry. 31: 236-40. PMID 18538397 DOI: 10.1016/j.ijlp.2008.04.007  0.56
2008 van Nimwegen L, de Haan L, van Beveren N, Laan W, van den Brink W, Linszen D. Obsessive-compulsive symptoms in a randomized, double-blind study with olanzapine or risperidone in young patients with early psychosis. Journal of Clinical Psychopharmacology. 28: 214-8. PMID 18344733 DOI: 10.1097/JCP.0b013e318166f520  0.6
2008 Schadé A, Marquenie LA, van Balkom AJ, Koeter MM, van den Brink W, van Dyck R. [The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: a randomised controlled trial]. Tijdschrift Voor Psychiatrie. 50: 137-48. PMID 18324601  1
2008 Zijlstra F, Booij J, van den Brink W, Franken IH. Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 18: 262-70. PMID 18077142 DOI: 10.1016/j.euroneuro.2007.11.002  1
2008 Schilt T, de Win MM, Jager G, Koeter MW, Ramsey NF, Schmand B, van den Brink W. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users. Psychological Medicine. 38: 1309-17. PMID 17988417 DOI: 10.1017/S0033291707002140  1
2008 Goudriaan AE, Oosterlaan J, De Beurs E, Van Den Brink W. The role of self-reported impulsivity and reward sensitivity versus neurocognitive measures of disinhibition and decision-making in the prediction of relapse in pathological gamblers. Psychological Medicine. 38: 41-50. PMID 17498322 DOI: 10.1017/S0033291707000694  1
2008 Jager G, de Win MM, van der Tweel I, Schilt T, Kahn RS, van den Brink W, van Ree JM, Ramsey NF. Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an FMRI study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 247-58. PMID 17460617 DOI: 10.1038/sj.npp.1301415  1
2007 Storosum JG, Wohlfarth T, Schene A, Elferink A, van Zwieten BJ, van den Brink W. Magnitude of effect of lithium in short-term efficacy studies of moderate to severe manic episode. Bipolar Disorders. 9: 793-8. PMID 18076528 DOI: 10.1111/j.1399-5618.2007.00445.x  0.48
2007 Wohlfarth T, Boer F, van den Brink W. Withdrawal of attention rather than pharmacological treatment affects suicide rates in depressed children and adolescents. The American Journal of Psychiatry. 164: 1908; author reply 1. PMID 18056249 DOI: 10.1176/appi.ajp.2007.07091448  0.48
2007 Fischer B, Oviedo-Joekes E, Blanken P, Haasen C, Rehm J, Schechter MT, Strang J, van den Brink W. Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics. Journal of Urban Health : Bulletin of the New York Academy of Medicine. 84: 552-62. PMID 17562183 DOI: 10.1007/s11524-007-9198-y  0.6
2007 Schilt T, de Win MM, Koeter M, Jager G, Korf DJ, van den Brink W, Schmand B. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Archives of General Psychiatry. 64: 728-36. PMID 17548754 DOI: 10.1001/archpsyc.64.6.728  1
2007 Jager G, de Win MM, Vervaeke HK, Schilt T, Kahn RS, van den Brink W, van Ree JM, Ramsey NF. Incidental use of ecstasy: no evidence for harmful effects on cognitive brain function in a prospective fMRI study. Psychopharmacology. 193: 403-14. PMID 17476480 DOI: 10.1007/s00213-007-0792-1  1
2007 Ooteman W, Koeter MW, Verheul R, Schippers GM, van den Brink W. The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 17: 558-66. PMID 17379484 DOI: 10.1016/j.euroneuro.2007.02.012  0.64
2007 van Nimwegen L, de Haan L, van Beveren N, van den Brink W, Linszen D. [Adolescence, schizophrenia and drug abuse: interactive vulnerability. A hypothesis]. Tijdschrift Voor Psychiatrie. 49: 169-78. PMID 17370223  0.6
2007 Schadé A, Marquenie LA, van Balkom AJ, Koeter MW, de Beurs E, van Dyck R, van den Brink W. Anxiety disorders: treatable regardless of the severity of comorbid alcohol dependence. European Addiction Research. 13: 109-15. PMID 17356283 DOI: 10.1159/000097941  1
2007 Marissen MA, Franken IH, Blanken P, van den Brink W, Hendriks VM. Cue exposure therapy for the treatment of opiate addiction: results of a randomized controlled clinical trial. Psychotherapy and Psychosomatics. 76: 97-105. PMID 17230050 DOI: 10.1159/000097968  0.6
2007 Marquenie LA, Schadé A, van Balkom AJ, Comijs HC, de Graaf R, Vollebergh W, van Dyck R, van den Brink W. Origin of the comorbidity of anxiety disorders and alcohol dependence: findings of a general population study. European Addiction Research. 13: 39-49. PMID 17172778 DOI: 10.1159/000095814  1
2007 Jager G, Van Hell HH, De Win MM, Kahn RS, Van Den Brink W, Van Ree JM, Ramsey NF. Effects of frequent cannabis use on hippocampal activity during an associative memory task. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 17: 289-97. PMID 17137758 DOI: 10.1016/j.euroneuro.2006.10.003  1
2007 de Win MM, Reneman L, Jager G, Vlieger EJ, Olabarriaga SD, Lavini C, Bisschops I, Majoie CB, Booij J, den Heeten GJ, van den Brink W. A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 458-70. PMID 17077812 DOI: 10.1038/sj.npp.1301225  1
2007 Popma A, Vermeiren R, Geluk CA, Rinne T, van den Brink W, Knol DL, Jansen LM, van Engeland H, Doreleijers TA. Cortisol moderates the relationship between testosterone and aggression in delinquent male adolescents. Biological Psychiatry. 61: 405-11. PMID 16950214 DOI: 10.1016/j.biopsych.2006.06.006  1
2007 van der Zanden BP, Dijkgraaf MG, Blanken P, van Ree JM, van den Brink W. Patterns of acquisitive crime during methadone maintenance treatment among patients eligible for heroin assisted treatment. Drug and Alcohol Dependence. 86: 84-90. PMID 16806740 DOI: 10.1016/j.drugalcdep.2006.05.021  1
2006 Rook EJ, Huitema AD, van den Brink W, van Ree JM, Beijnen JH. Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature. Current Clinical Pharmacology. 1: 109-18. PMID 18666382 DOI: 10.2174/157488406775268219  1
2006 Dom G, De Wilde B, Hulstijn W, van den Brink W, Sabbe B. Decision-making deficits in alcohol-dependent patients with and without comorbid personality disorder. Alcoholism, Clinical and Experimental Research. 30: 1670-7. PMID 17010134 DOI: 10.1111/j.1530-0277.2006.00202.x  1
2006 Marissen MA, Franken IH, Waters AJ, Blanken P, van den Brink W, Hendriks VM. Attentional bias predicts heroin relapse following treatment. Addiction (Abingdon, England). 101: 1306-12. PMID 16911730 DOI: 10.1111/j.1360-0443.2006.01498.x  1
2006 Rook EJ, Huitema AD, van den Brink W, Hillebrand MJ, van Ree JM, Beijnen JH. Screening for illicit heroin use in patients in a heroin-assisted treatment program. Journal of Analytical Toxicology. 30: 390-4. PMID 16872571  1
2006 Zinkstok J, Schmitz N, van Amelsvoort T, de Win M, van den Brink W, Baas F, Linszen D. The COMT val158met polymorphism and brain morphometry in healthy young adults. Neuroscience Letters. 405: 34-9. PMID 16857316 DOI: 10.1016/j.neulet.2006.06.034  1
2006 Dom G, De Wilde B, Hulstijn W, van den Brink W, Sabbe B. Behavioural aspects of impulsivity in alcoholics with and without a cluster-B personality disorder. Alcohol and Alcoholism (Oxford, Oxfordshire). 41: 412-20. PMID 16782972 DOI: 10.1093/alcalc/agl030  1
2006 Rook EJ, van Zanten AP, Van den Brink W, van Ree JM, Beijnen JH. Mast cell mediator tryptase levels after inhalation or intravenous administration of high doses pharmaceutically prepared heroin. Drug and Alcohol Dependence. 85: 185-90. PMID 16765536 DOI: 10.1016/j.drugalcdep.2006.04.013  1
2006 Klous MG, Lee WC, Van den Brink W, Van Ree JM, Beijnen JH. Volatilisation of diacetylmorphine: in vitro simulation of 'chasing the dragon'. Die Pharmazie. 61: 438-45. PMID 16724542  1
2006 Philipse MW, Koeter MW, van der Staak CP, van den Brink W. Static and dynamic patient characteristics as predictors of criminal recidivism: A prospective study in a Dutch forensic psychiatric sample. Law and Human Behavior. 30: 309-27. PMID 16645888 DOI: 10.1007/s10979-006-9013-4  0.64
2006 Klous MG, Lee W, Hillebrand MJ, van den Brink W, van Ree JM, Beijnen JH. Analysis of diacetylmorphine, caffeine, and degradation products after volatilization of pharmaceutical heroin for inhalation. Journal of Analytical Toxicology. 30: 6-13. PMID 16620525  1
2006 Rook EJ, Huitema AD, van den Brink W, van Ree JM, Beijnen JH. Population pharmacokinetics of heroin and its major metabolites. Clinical Pharmacokinetics. 45: 401-17. PMID 16584286 DOI: 10.2165/00003088-200645040-00005  1
2006 Reneman L, Schilt T, de Win MM, Booij J, Schmand B, van den Brink W, Bakker O. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users. Journal of Psychopharmacology (Oxford, England). 20: 389-99. PMID 16574713 DOI: 10.1177/0269881106063266  1
2006 Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W. Psychophysiological determinants and concomitants of deficient decision making in pathological gamblers. Drug and Alcohol Dependence. 84: 231-9. PMID 16574343 DOI: 10.1016/j.drugalcdep.2006.02.007  1
2006 Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W. Neurocognitive functions in pathological gambling: a comparison with alcohol dependence, Tourette syndrome and normal controls. Addiction (Abingdon, England). 101: 534-47. PMID 16548933 DOI: 10.1111/j.1360-0443.2006.01380.x  1
2006 Ooteman W, Koeter M, Verheul R, Schippers G, Van den Brink W. Development and validation of the Amsterdam Motives for Drinking Scale (AMDS): an attempt to distinguish relief and reward drinkers. Alcohol and Alcoholism (Oxford, Oxfordshire). 41: 284-92. PMID 16540493 DOI: 10.1093/alcalc/agl012  0.84
2006 Jager G, Kahn RS, Van Den Brink W, Van Ree JM, Ramsey NF. Long-term effects of frequent cannabis use on working memory and attention: an fMRI study. Psychopharmacology. 185: 358-68. PMID 16521034 DOI: 10.1007/s00213-005-0298-7  1
2006 de Win MM, Schilt T, Reneman L, Vervaeke H, Jager G, Dijkink S, Booij J, van den Brink W. Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study. Journal of Psychopharmacology (Oxford, England). 20: 226-35. PMID 16510480 DOI: 10.1177/0269881106063275  1
2006 Reneman L, de Win MM, van den Brink W, Booij J, den Heeten GJ. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects. Journal of Psychopharmacology (Oxford, England). 20: 164-75. PMID 16510475 DOI: 10.1177/0269881106061515  1
2006 de Bruijn C, van den Brink W, de Graaf R, Vollebergh WA. The three year course of alcohol use disorders in the general population: DSM-IV, ICD-10 and the Craving Withdrawal Model. Addiction (Abingdon, England). 101: 385-92. PMID 16499511 DOI: 10.1111/j.1360-0443.2006.01327.x  0.64
2006 Van den Brink W, Montgomery SA, Van Ree JM, van Zwieten-Boot BJ. ECNP consensus meeting March 2003 guidelines for the investigation of efficacy in substance use disorders. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 16: 224-30. PMID 16442270 DOI: 10.1016/j.euroneuro.2005.12.003  1
2006 Rook EJ, van Ree JM, van den Brink W, Hillebrand MJ, Huitema AD, Hendriks VM, Beijnen JH. Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients. Basic & Clinical Pharmacology & Toxicology. 98: 86-96. PMID 16433897 DOI: 10.1111/j.1742-7843.2006.pto_233.x  1
2006 Ooteman W, Koeter MW, Vserheul R, Schippers GM, van den Brink W. Measuring craving: an attempt to connect subjective craving with cue reactivity. Alcoholism, Clinical and Experimental Research. 30: 57-69. PMID 16433732 DOI: 10.1111/j.1530-0277.2006.00019.x  0.64
2006 Hogen Esch AJ, van der Heide S, van den Brink W, van Ree JM, Bruynzeel DP, Coenraads PJ. Contact allergy and respiratory/mucosal complaints from heroin (diacetylmorphine). Contact Dermatitis. 54: 42-9. PMID 16426293 DOI: 10.1111/j.0105-1873.2006.00745.x  1
2006 Marquenie LA, Schadé A, Van Balkom AJ, Koeter M, Frenken S, van den Brink W, van Dyck R. Comorbid phobic disorders do not influence outcome of alcohol dependence treatment. Results of a naturalistic follow-up study. Alcohol and Alcoholism (Oxford, Oxfordshire). 41: 168-73. PMID 16352656 DOI: 10.1093/alcalc/agh252  1
2006 van der Zanden BP, Dijkgraaf MG, Blanken P, de Borgie CA, van Ree JM, van den Brink W. Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population. Drug and Alcohol Dependence. 82: 111-8. PMID 16168573 DOI: 10.1016/j.drugalcdep.2005.08.012  1
2005 De Win MM, Jager G, Vervaeke HK, Schilt T, Reneman L, Booij J, Verhulst FC, Den Heeten GJ, Ramsey NF, Korf DJ, Van den Brink W. The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. International Journal of Methods in Psychiatric Research. 14: 167-85. PMID 16395871 DOI: 10.1002/mpr.6  1
2005 Marissen MA, Franken IH, Blanken P, Hendriks VM, van den Brink W. The relation between social desirability and different measures of heroin craving. Journal of Addictive Diseases. 24: 91-103. PMID 16368659  0.6
2005 de Bruijn C, van den Brink W. Validity of the one-criterion threshold for an alcohol abuse diagnosis. The American Journal of Psychiatry. 162: 2400; author reply 2. PMID 16330621 DOI: 10.1176/appi.ajp.162.12.2400  1
2005 Franken IH, Booij J, van den Brink W. The role of dopamine in human addiction: from reward to motivated attention. European Journal of Pharmacology. 526: 199-206. PMID 16256105 DOI: 10.1016/j.ejphar.2005.09.025  1
2005 Klous MG, Rook EJ, Hillebrand MJ, van den Brink W, van Ree JM, Beijnen JH. Deuterodiacetylmorphine as a marker for use of illicit heroin by addicts in a heroin-assisted treatment program. Journal of Analytical Toxicology. 29: 564-9. PMID 16168180  1
2005 Dom G, Sabbe B, Hulstijn W, van den Brink W. Substance use disorders and the orbitofrontal cortex: systematic review of behavioural decision-making and neuroimaging studies. The British Journal of Psychiatry : the Journal of Mental Science. 187: 209-20. PMID 16135857 DOI: 10.1192/bjp.187.3.209  1
2005 de Bruijn C, van den Brink W, de Graaf R, Vollebergh WA. Alcohol abuse and dependence criteria as predictors of a chronic course of alcohol use disorders in the general population. Alcohol and Alcoholism (Oxford, Oxfordshire). 40: 441-6. PMID 16009673 DOI: 10.1093/alcalc/agh183  0.64
2005 van den Bosch LM, Koeter MW, Stijnen T, Verheul R, van den Brink W. Sustained efficacy of dialectical behaviour therapy for borderline personality disorder. Behaviour Research and Therapy. 43: 1231-41. PMID 16005708 DOI: 10.1016/j.brat.2004.09.008  0.64
2005 Dijkgraaf MG, van der Zanden BP, de Borgie CA, Blanken P, van Ree JM, van den Brink W. Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials. Bmj (Clinical Research Ed.). 330: 1297. PMID 15933353 DOI: 10.1136/bmj.330.7503.1297  1
2005 Klous MG, Van den Brink W, Van Ree JM, Beijnen JH. Development of pharmaceutical heroin preparations for medical co-prescription to opioid dependent patients. Drug and Alcohol Dependence. 80: 283-95. PMID 15916865 DOI: 10.1016/j.drugalcdep.2005.04.008  0.6
2005 Schadé A, Marquenie LA, van Balkom AJ, Koeter MW, de Beurs E, van den Brink W, van Dyck R. The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: a randomized controlled trial. Alcoholism, Clinical and Experimental Research. 29: 794-800. PMID 15897725 DOI: 10.1097/01.ALC.0000163511.24583.33  1
2005 de Win MM, Habraken JB, Reneman L, van den Brink W, den Heeten GJ, Booij J. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 996-1005. PMID 15770240 DOI: 10.1038/sj.npp.1300683  1
2004 de Win MM, Reneman L, Reitsma JB, den Heeten GJ, Booij J, van den Brink W. Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender. Psychopharmacology. 173: 376-82. PMID 14726997 DOI: 10.1007/s00213-003-1723-4  1
2002 Reneman L, Booij J, Lavalaye J, de Bruin K, Reitsma JB, Gunning B, den Heeten GJ, van Den Brink W. Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study--preliminary report. Psychopharmacology. 159: 335-40. PMID 11862367 DOI: 10.1007/s00213-001-0930-0  1
2001 Reneman L, Booij J, Majoie CB, Van Den Brink W, Den Heeten GJ. Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach. Human Psychopharmacology. 16: 579-588. PMID 12404537 DOI: 10.1002/hup.347  1
2001 Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet. 358: 1864-9. PMID 11741626 DOI: 10.1016/S0140-6736(01)06888-X  1
2001 Reneman L, Lavalaye J, Schmand B, de Wolff FA, van den Brink W, den Heeten GJ, Booij J. Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings. Archives of General Psychiatry. 58: 901-6. PMID 11576026  1
2000 Reneman L, Booij J, Schmand B, van den Brink W, Gunning B. Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology. 148: 322-4. PMID 10755746  1
1994 Ormel J, van den Brink W, van der Meer K, Jenner J, Giel R. [Prevalence, indication and course of depression in family practice]. Nederlands Tijdschrift Voor Geneeskunde. 138: 123-6. PMID 8295637  0.32
1992 Wiznitzer M, Verhulst FC, van den Brink W, Koeter M, van der Ende J, Giel R, Koot HM. Detecting psychopathology in young adults: the Young Adult Self Report, the General Health Questionnaire and the Symptom Checklist as screening instruments. Acta Psychiatrica Scandinavica. 86: 32-7. PMID 1414396  0.32
1990 Ormel J, Van Den Brink W, Koeter MW, Giel R, Van Der Meer K, Van De Willige G, Wilmink FW. Recognition, management and outcome of psychological disorders in primary care: a naturalistic follow-up study. Psychological Medicine. 20: 909-23. PMID 2284397  0.32
1989 van den Brink W, Koeter MW, Ormel J, Dijkstra W, Giel R, Slooff CJ, Wohlfarth TD. Psychiatric diagnosis in an outpatient population. A comparative study of PSE-Catego and DSM-III. Archives of General Psychiatry. 46: 369-72. PMID 2930333 DOI: 10.1001/archpsyc.1989.01810040075011  1
1989 Ormel J, Koeter MW, van den Brink W, Giel R. Concurrent validity of GHQ-28 and PSE as measures of change. Psychological Medicine. 19: 1007-13. PMID 2594877  0.32
Show low-probability matches.